Onyx Bridge Wealth Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Onyx Bridge Wealth Group's VRTX Position: Q3 2026 in Review
Onyx Bridge Wealth Group increased its Vertex Pharmaceuticals (VRTX) stake by 20% in Q3 2026, buying an estimated $44.5K and bringing the position to 518 shares worth $271K. The position accounts for 0.02% of the portfolio, ranked #335.
Onyx Bridge Wealth Group first reported a position in VRTX in Q3 2024 and has held it in 5 quarters since. The position peaked at $337K in Q3 2024. 1,772 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Onyx Bridge Wealth Group held 518 shares of Vertex Pharmaceuticals worth $271K as of Q3 2026.
- Onyx Bridge Wealth Group bought 87 Vertex Pharmaceuticals shares in Q3 2026, an estimated $44.5K.
- Vertex Pharmaceuticals made up 0.02% of Onyx Bridge Wealth Group's portfolio in Q3 2026, its #335 holding.
- Onyx Bridge Wealth Group first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
- Onyx Bridge Wealth Group's Vertex Pharmaceuticals position peaked at $337K in Q3 2024.
- 1,772 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Onyx Bridge Wealth Group's 13F filing for Q3 2026, filed 16 Oct 2026.